Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
Clinical Lymphoma Myeloma and Leukemia · 2024-11 · 24 (11) · 778-782
DOI: 10.1016/j.clml.2024.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024-11. Verfasst von Meryl Colton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO. Electronic address:…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Novartis Pharmaceuticals Corp.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO. Electronic address: Meryl.colton@cuanschutz.edu.
- Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO.
- Adaptive Biotechnologies, Seattle WA.
Förderung
- Novartis Pharmaceuticals Corp
Zitieren
APA
Colton, M., Purev, E., Haverkos, B., Bair, S., Jasem, J., Jacob, A., & Kamdar, M. (2024). Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy. Clinical Lymphoma Myeloma and Leukemia, 24(11), 778-782. https://doi.org/10.1016/j.clml.2024.06.006
Vancouver
Colton M, Purev E, Haverkos B, Bair S, Jasem J, Jacob A, et al. Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy. Clinical Lymphoma Myeloma and Leukemia. 2024;24(11):778-782. doi:10.1016/j.clml.2024.06.006
BibTeX
@article{Colton2024,
author = {Colton, Meryl and Purev, Enkhtsetseg and Haverkos, Bradley and Bair, Steven and Jasem, Jagar and Jacob, Allison and Kamdar, Manali},
title = {Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2024},
volume = {24},
number = {11},
pages = {778--782},
doi = {10.1016/j.clml.2024.06.006}
}
EUVIMED